evidence-based medicine

Archive for 4月 2004

放射線治療の影響

leave a comment »

眼窩部放射線治療の成果と放射線障害(甲状腺眼症)
Ophthalmology. 2002 Nov;109(11):2100-7.
The aftermath of orbital radiotherapy for graves’ ophthalmopathy.
Gorman CA, Garrity JA, Fatourechi V, Bahn RS, Petersen IA, Stafford SL, Earle JD, Forbes GS, Kline RW, Buettner H, Robertson DM, Bergstralh EJ, Offord KP, Rademacher DM, Stanley NM, Bartley GB.
Department of Medicine, Mayo Clinic, Rochester, Minnesota. Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota 55905, USA.
放射線治療後の眼部神経性筋強直(きょうちょく)
Strabismus. 2002 Jun;10(2):119-24.
Ocular neuromyotonia: a case report.
Fricke J, Neugebauer A, Kirsch A, Russmann W.
Department of Strabismology and Neuro-ophthalmology, Eye Clinic, University of Cologne, Germany.

Written by support

2004/04/29 at 10:16

カテゴリー: Uncategorized

網膜剥離手術後の屈折度数変化

leave a comment »

網膜剥離手術(強膜バックリング)後の屈折、角膜形状変化
Ophthalmology. 1997 May;104(5):831-7.
Corneal shape changes after scleral buckling surgery.
Hayashi H, Hayashi K, Nakao F, Hayashi F.
Department of Ophthalmology, School of Medicine, Fukuoka University, Japan.
Jpn J Ophthalmol. 2000 Mar-Apr;44(2):132-8.
Analysis of changes in corneal shape and refraction following scleral buckling surgery.
Okada Y, Nakamura S, Kubo E, Oishi N, Takahashi Y, Akagi Y.
Department of Ophthalmology, Fukui Medical University, Yoshida-gun Fukui, Japan.
Klin Monatsbl Augenheilkd. 1997 Mar;210(3):144-6.
[Modification of axial length and astigmatism by scleral buckling surgery]
Grimm G, Aust W, Stark M.
Augenklinik des Lehrkrankenhauses Kassel.

Written by support

2004/04/27 at 09:53

カテゴリー: Uncategorized

塩酸ブナゾシン点眼液の副作用

leave a comment »

選択的交感神経α1受容体遮断薬ブナゾシンは海外での臨床治験中0.3%点眼液において、瞳孔が小さくなる(縮瞳)、まぶたが下がる(眼瞼下垂)、白目が赤くなる(目の充血)などの副作用が発現しています。
Br J Ophthalmol. 1991 Jul;75(7):411-3.
Ocular responses in healthy subjects to topical bunazosin 0.3%–an alpha 1-adrenoceptor antagonist.
Trew DR, Wright LA, Smith SE.
Division of Pharmacological Sciences and Toxicology, United Medical School, London.
国内で緑内障薬として市販されているものは 低濃度0.01%液だけで、眼圧下降効果の面というより従来の緑内障薬に比して角膜障害が少ないなどの理由で保健適応となった薬剤です。
http://www.mhlw.go.jp/shingi/0104/txt/s0427-2.txt
本剤(0.01%)は国内での臨床治験中にも、副作用「結膜充血」は投与症例の2%程度に見られています(商品名 デタントール0.01%点眼液)。

Written by support

2004/04/23 at 15:16

カテゴリー: Uncategorized

黄斑部網膜上膜と硝子体手術

leave a comment »

網膜上膜の術後視力等について
Nippon Ganka Gakkai Zasshi. 2004 Jan;108(1):18-22.
[The surgical outcome of vitrectomy for idiopathic epiretinal membranes and foveal thickness before and after surgery]
Ishida M, Takeuchi S, Nakamura M, Morimoto K, Okisaka S.
Second Department of Ophthalmology, Toho University School of Medicine, 2-17-6 Ohashi, Meguro-ku, Tokyo 153-8515, Japan.

Written by support

2004/04/22 at 16:38

カテゴリー: Uncategorized

円錐角膜

leave a comment »

片眼性円錐角膜患者の追跡調査
Ophthalmology. 2004 Mar;111(3):440-6.
Longitudinal study of the normal eyes in unilateral keratoconus patients.
Li X, Rabinowitz YS, Rasheed K, Yang H.
Division of Medical Genetics, Medical Genetics Birth Defects Center, Steven Spielberg Research Center, Los Angeles, California, USA.
アトピー皮膚炎と眼合併症
Arerugi. 1994 Jul;43(7):796-9.
[Eye complications in atopic dermatitis]
Ohmachi N, Sasabe T, Kojima M, Adachi J, Endo K, Fukuzumi T, Aoki T.
Department of Ophthalmology, Osaka Prefectural Habikino Hospital.

Written by support

2004/04/19 at 17:02

カテゴリー: Uncategorized